Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-017797
Filing Date
2022-05-12
Accepted
2022-05-12 17:47:26
Documents
1
Period of Report
2022-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4218
  Complete submission text file 0000899243-22-017797.txt   5712
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
McHugh Julie (Reporting) CIK: 0001487179 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36569 | Film No.: 22919312

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances